Puregon (follitropin beta): Reviews and patient testimonials

Puregon 300 IU/0.36 ml, 600 IU/0.72 ml , 900 IU/1.08 ml solution for injection

In adult females:

Puregon is indicated for the treatment of female infertility in the following clinical situations:

• Anovulation (including polycystic ovarian syndrome, PCOS) in women who have been unresponsive to treatment with clomifene citrate.

• Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)].

In adult males:

• Deficient spermatogenesis due to hypogonadotrophic hypogonadism.

Puregon 50 IU/0.5 ml Solution for injection, Puregon 100 IU/0.5 ml Solution for injection

In adult females:

Puregon is indicated for the treatment of female infertility in the following clinical situations:

• Anovulation (including polycystic ovarian syndrome, PCOS) in women who have been unresponsive to treatment with clomifene citrate.

• Controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (IVF/ET), gamete intra-fallopian transfer (GIFT) and intracytoplasmic sperm injection (ICSI)].

In adult males:

• Deficient spermatogenesis due to hypogonadotrophic hypogonadism.

Route of administration: Injectable
Molecule: follitropin beta